EKSO — Ekso Bionics Holdings Income Statement
0.000.00%
- $19.17m
- $16.22m
- $18.28m
- 33
- 47
- 41
- 35
Annual income statement for Ekso Bionics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13.9 | 8.88 | 11.2 | 12.9 | 18.3 |
Cost of Revenue | |||||
Gross Profit | 6.76 | 5.07 | 6.75 | 6.21 | 9.08 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30.8 | 22.2 | 24 | 28.5 | 33.4 |
Operating Profit | -16.9 | -13.3 | -12.7 | -15.6 | -15.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12.1 | -15.8 | -9.76 | -15.1 | -15.2 |
Net Income After Taxes | -12.1 | -15.8 | -9.76 | -15.1 | -15.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.1 | -15.8 | -9.76 | -15.1 | -15.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.1 | -15.8 | -10.8 | -15.1 | -15.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.48 | -2.15 | -0.975 | -1.16 | -1.1 |